Amos Pasternack

Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia

M. H. Frick, Olli Elo, Kauko Haapa et al. · New England Journal of Medicine · 1987 · 3.9K citations

Coeliac disease--associated disorders and survival.

Pekka Collin, Timo Reunala, ­Eero Pukkala et al. · Gut · 1994 · 472 citations · Full text

Prevention of the Angiographic Progression of Coronary and Vein-Graft Atherosclerosis by Gemfibrozil After Coronary Bypass Surgery in Men With Low Levels of HDL Cholesterol

M. H. Frick, Mikko Syvänne, Markku S. Nieminen et al. · Circulation · 1997 · 386 citations

Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment

K. O. Pietlla, Aimo Harmoinen, J. Jokiniitty et al. · European Heart Journal · 1996 · 263 citations · Full text

New biomarker evidence of oxidative DNA damage in patients with non‐insulin‐dependent diabetes mellitus

Janne Leinonen, Terho Lehtimäki, Shinya Toyokuni et al. · FEBS Letters · 1997 · 262 citations · Full text